Biosimilar IPR List and Status Update

AIA Review Number	Filing Date	Institution Decision Date	Patent Number	Application Number	Petitioner	Patent Owner	Status
IPR2016-00408	12/29/2015	07/07/2016	8889135	10163657	Boehringer Ingelheim GmbH	AbbVie Biotechnology Ltd.	Trial Instituted
IPR2016-00409	12/29/2015	07/07/2016	8889135	10163657	Boehringer Ingelheim GmbH	AbbVie Biotechnology Ltd.	Trial Instituted
IPR2016-00172	11/09/2015	05/17/2016	8889135	10163657	Coherus BioSciences Inc.	AbbVie Biotechnology Ltd.	Trial Instituted
IPR2015-01514	06/26/2015	01/14/2016	8916157	14453461	Amgen Inc	AbbVie Biotechnology Ltd.	Terminated
IPR2015-01517	06/26/2015	01/14/2016	8916158	14453490	Amgen Inc	AbbVie Biotechnology Ltd.	Terminated
IPR2016-00188	12/07/2015	06/13/2016	9017680	14542529	Coherus BioSciences Inc.	AbbVie Biotechnology Ltd.	Trial Instituted
IPR2016-00189	12/07/2015	06/13/2016	9073987	14292759	Coherus BioSciences Inc.	AbbVie Biotechnology Ltd.	Trial Instituted
IPR2016-01018	05/09/2016		9114166	14558182	Coherus BioSciences Inc.	AbbVie Biotechnology Ltd.	Pending
IPR2016-01542	08/05/2016		8952138	12820087	Apotex Inc.	Amgen Inc.	Pending
IPR2015-00418	12/15/2014	07/13/2015	8329172	11840956	Boehringer Ingelheim Pharmaceuticals, Inc.	Biogen Inc.	Terminated
IPR2016-00915	04/18/2016		8349321	12572978	Swiss Pharma International AG	Biogen MA Inc.	Pending
IPR2016-00912	04/18/2016		8815236	13676866	Swiss Pharma International AG	Biogen MA Inc.	Pending
IPR2016-00916	04/18/2016		8900577	13605590	Swiss Pharma International AG	Biogen MA Inc.	Pending
IPR2015-01537	07/02/2015	01/15/2016	8476239	12086876	Momenta Pharmaceuticals, Inc.	Bristol-Myers Squibb Company	Trial Instituted
IPR2016-00460	01/15/2016	06/08/2016	6331415	07205419	Genzyme Corporation	GENENTECH, INC.	Terminated
IPR2016-00710	03/03/2016	09/08/2016	6331415	07205419	Mylan Pharmaceuticals Inc.	Genentech, Inc.	Trial Instituted
IPR2016-01373	07/07/2016		6331415	07205419	Merck Sharp & Dohme Corp.	Genentech, Inc.	Pending
IPR2016-00383	12/30/2015	06/23/2016	6331415	07205419	GENZYME CORPORATION	Genentech Inc.	Terminated
IPR2015-01624	07/27/2015	02/05/2016	6331415	07205419	Sanofi-Aventis U.S. LLC	Genentech, Inc.	Terminated
IPR2016-01693	08/30/2016		6407213	08146206	Mylan Pharmaceuticals Inc.	GENENTECH, INC.	Pending
IPR2016-01694	08/30/2016		6407213	08146206	Mylan Pharmaceuticals Inc.	GENENTECH, INC.	Pending
IPR2016-01608	08/16/2016		6716602	10000655	bioeq IP AG	GENENTECH,INC.	Pending
IPR2016-01614	08/15/2016		7820161	09564288	Celltrion, Inc.	Genentech, Inc.	Pending
IPR2015-00415	12/15/2014	07/17/2015	7820161	09564288	Boehringer Ingelheim Pharmaceuticals, Inc.	Genentech, Inc.	Terminated
IPR2015-01744	08/17/2015	10/06/2015	7820161	09564288	Celltrion, Inc.	Genentech, Inc.	Trial Denied
IPR2015-01733	08/14/2015	10/06/2015	7976838	12052606	Celltrion, Inc.	Genentech, Inc.	Trial Denied
IPR2015-00417	12/15/2014	07/14/2015	7976838	12052606	Boehringer Ingelheim Pharmaceuticals, Inc.	Genentech, Inc.	Terminated
IPR2016-01667	08/24/2016		7976838	12052606	Celltrion Inc.	Genentech, Inc.	Pending
IPR2015-01792	08/22/2015	03/11/2016	8163522	08444791	Coalition for Affordable Drugs V LLC	Hoffmann-La Roche Inc.	Terminated
IPR2014-00842	05/29/2014	12/09/2014	7575748	11488545	Phigenix, Inc.	ImmunoGen, Inc.	Terminated
IPR2013-00365	06/19/2013	10/24/2013	6747002	09569612	Hospira, Inc.	Janssen Pharmaceuticals, Inc.	Trial Denied
IPR2015-00990	04/01/2015	10/23/2015	7056886	09750022	Coalition for Affordable Drugs II LLC	NPS Pharmaceuticals, Inc.	Trial Instituted
IPR2015-01093	04/23/2015	10/23/2015	7056886	09750022	Coalition for Affordable Drugs II, LLC	NPS Pharmaceuticals, Inc.	Trial Instituted
IPR2016-00258	11/25/2015	05/25/2016	9051556	13829706	Green Cross Corporation	Shire Human Genetic Therapies, Inc.	Trial Instituted